Investor News

Home>News>Investor News

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

https://health.ucsd.edu/news/releases/Pages/2019-04-01-UC-San-Diego-Health-Treats-Cancer-Patient-with-Stem-Cell-Derived-Natural-Killer-Cells.aspx

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells
Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

April 01, 2019  |  Yadira Galindo

After 10 years in remission, Derek Ruff’s cancer returned, this […]

2019-04-02T02:22:48+11:00April 2nd, 2019|

Tom’s Long Fight

Tom Long’s battle with Multiple Myeloma

Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday Project to help raise awareness for blood cancer and the need for more research in Australia.  The story is heartbreaking, Tom is hanging on to hope.  Hope that a CAR-T cell treatment that he has to […]

2019-03-25T23:18:28+11:00March 25th, 2019|

Australia is handicapped in the delivery of cell therapies, says Alan Trounson

THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.

This is not a distant vision. It is happening right here, right now. A research team, […]

2019-03-21T01:00:32+11:00March 21st, 2019|

Safer cells for immunotherapy

Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019

Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]

2019-02-13T05:02:22+11:00February 13th, 2019|

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

https://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs

UNIVERSITY OF CALIFORNIA – SAN DIEGO

Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]

2018-12-20T02:44:33+11:00December 20th, 2018|

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

Sydney Morning Herald (By Esther Han)

19 December 2018 — 12:00am

https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html

A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.

Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]

2018-12-20T00:05:33+11:00December 19th, 2018|

The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System

An interview with UK immunologist Daniel Davis on national Public Radio’s “Fresh Air” is a good discussion about his new book for a general audience.

https://www.npr.org/2018/11/26/670793745/the-beautiful-cure-reveals-the-profound-power-of-the-immune-system

November 26, 20181:51 PM ET Heard on Fresh Air

Immunologist Daniel Davis says scientists are harnessing the power of the immune system to create new medications […]

2018-11-29T03:48:15+11:00November 29th, 2018|
Go to Top